LTFS
ACHN

Ladenburg Thalmann Financial Services’s Achillion Pharmaceuticals ACHN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
300
– – ﹤0.01% 5150
2019
Q3 		$1K Hold
300
– – ﹤0.01% 5230
2019
Q2 		$1K Hold
300
– – ﹤0.01% 5228
2019
Q1 		$1K Hold
300
– – ﹤0.01% 5174
2018
Q4 		$0 Hold
300
– – ﹤0.01% 5451
2018
Q3 		$1K Sell
300
-2,579
-90% -$7.69K ﹤0.01% 5094
2018
Q2 		$11K Hold
2,879
– – ﹤0.01% 4224
2018
Q1 		$11K Sell
2,879
-400
-12% -$1.31K ﹤0.01% 4224
2017
Q4 		$9K Buy
3,279
+1,200
+58% +$4.36K ﹤0.01% 4270
2017
Q3 		$9K Sell
2,079
-500
-19% -$2.22K ﹤0.01% 4153
2017
Q2 		$12K Sell
2,579
-6,900
-73% -$27.7K ﹤0.01% 3928
2017
Q1 		$40K Buy
9,479
+9,400
+11,899% +$39K ﹤0.01% 3084
2016
Q4 		$0 Sell
79
-100
-56% -$532 ﹤0.01% 5010
2016
Q3 		$2K Hold
179
– – ﹤0.01% 4545
2016
Q2 		$2K Sell
179
-2,975
-94% -$25.5K ﹤0.01% 4472
2016
Q1 		$25K Sell
3,154
-2,100
-40% -$15.4K ﹤0.01% 3114
2015
Q4 		$57K Sell
5,254
-9,058
-63% -$82.3K ﹤0.01% 2466
2015
Q3 		$99K Hold
14,312
– – ﹤0.01% 2003
2015
Q2 		$127K Hold
14,312
– – ﹤0.01% 1932
2015
Q1 		$141K Hold
14,312
– – ﹤0.01% 1828
2014
Q4 		$175K Sell
14,312
-460
-3% -$5.62K ﹤0.01% 1529
2014
Q3 		$147K Sell
14,772
-740
-5% -$6.87K ﹤0.01% 1377
2014
Q2 		$117K Sell
15,512
-12,188
-44% -$48.6K ﹤0.01% 1507
2014
Q1 		$91K Buy
27,700
+12,700
+85% +$44.4K ﹤0.01% 1563
2013
Q4 		$50K Buy
15,000
+12,500
+500% +$36.3K ﹤0.01% 1923
2013
Q3 		$8K Hold
2,500
– – ﹤0.01% 2983
2013
Q2 		$20K Buy
+2,500
New +$19.1K ﹤0.01% 2357

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ACHN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Achillion Pharmaceuticals (ACHN) position steady in Q4 2019 at 300 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5150.

Ladenburg Thalmann Financial Services first reported a position in ACHN in Q2 2013 and has held it in 27 quarters since. The position peaked at $175K in Q4 2014. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 300 shares of Achillion Pharmaceuticals worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Achillion Pharmaceuticals share count unchanged in Q4 2019.
  • Achillion Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5150 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Achillion Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Achillion Pharmaceuticals position peaked at $175K in Q4 2014.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.